Get the Stockscreener App
0.397
3.52%
0.0135
Pre-market:
.39
-0.007
-1.76%
Biodesix Inc stock is traded at $0.397, with a volume of 832.72K.
It is up +3.52% in the last 24 hours and up +26.96% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$0.3835
Open:
$0.38
24h Volume:
832.72K
Relative Volume:
0.10
Market Cap:
$58.19M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-0.6108
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
-11.19%
1M Performance:
+26.96%
6M Performance:
-59.70%
1Y Performance:
-76.92%
1-Day Range:
$0.372
$0.3994
1-Week Range:
$0.3702
$0.4329
52-Week Range:
$0.1718
$2.04
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.397 | 56.23M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
485.04 | 183.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
210.22 | 149.76B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
653.95 | 53.12B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.87 | 34.17B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
189.40 | 32.34B | 15.50B | 1.33B | 2.16B | 7.34 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jul-26-24 | Initiated | Craig Hallum | Buy |
| May-13-24 | Initiated | TD Cowen | Buy |
| May-03-24 | Initiated | Lake Street | Buy |
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Is This the Dip to Buy in Biodesix Inc.Weekly Trade Review & Reliable Breakout Stock Forecasts - beatles.ru
Biodesix (NASDAQ:BDSX) Announces Quarterly Earnings Results - MarketBeat
Can Biodesix Inc. Outperform Peers After Recent PullbackExit Point & Proven Capital Preservation Methods - thegnnews.com
Biodesix, Inc. Reports Strong Q2 2025 Growth - MSN
Biodesix at Canaccord Conference: Strategic Expansion in Diagnostics By Investing.com - Investing.com Canada
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - 富途牛牛
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript - Insider Monkey
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price - 富途牛牛
Earnings Release: Here's Why Analysts Cut Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$1.80 - Yahoo Finance
Biodesix 2025 Q2 Earnings Revenue Grows 11.7% Amid Expanding Losses - AInvest
Biodesix reports strong Q2 revenue growth - BizWest
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Biodesix, Inc. shares fall 9.84% intraday despite Q2 revenue beating estimates. - AInvest
Transcript : Biodesix, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Biodesix Plunges 11.63% on Q2 Loss, Revenue Surprise - AInvest
Biodesix Reports Strong Q2 2025 Revenue Growth - TipRanks
Biodesix Maintains Hold Rating Amid Revenue Growth and Cash Flow Challenges - AInvest
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... By GuruFocus - Investing.com Canada
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
Biodesix Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biodesix Outpaces Expectations With Lung Test Growth And Upbeat Outlook - Finimize
Diagnostic firm Biodesix Q2 revenue beats estimates - MarketScreener
Biodesix earnings missed, revenue topped estimates By Investing.com - Investing.com South Africa
Biodesix earnings missed, revenue topped estimates - Investing.com
Biodesix Announces Second Quarter 2025 Results and Highlights - GlobeNewswire
Biodesix Soars 14.1% on Conference Presentation - AInvest
Biodesix Stock Soars 12.82% on Strong Q1 Earnings - AInvest
Biodesix shares rise 4.26% premarket after announcing CEO and CFO to present at Canaccord Genuity 45th Annual Growth Conference. - AInvest
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Biodesix shares rise 1.30% premarket after announcing CEO and CFO to present at Canaccord Genuity 45th Annual Growth Conference. - AInvest
Biodesix's Strategic Momentum in Diagnostic Innovation and Market Expansion: A Compelling Buy in the High-Growth Diagnostics Sector - AInvest
Biodesix Leadership Team Set for Exclusive Fireside Chat at Major Growth Conference - Stock Titan
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating - 富途牛牛
Why is Biodesix Inc. stock attracting strong analyst attentionMaximize portfolio value with timely trades - Jammu Links News
What institutional investors are buying Biodesix Inc. stockAchieve rapid portfolio appreciation today - Jammu Links News
What makes Biodesix Inc. stock price move sharplyFind market-beating stocks for your portfolio - Jammu Links News
Is Biodesix Inc. stock overvalued or undervaluedCapitalize on emerging market opportunities - Jammu Links News
Biodesix Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - Jammu Links News
Biodesix (BDSX) to Release Earnings on Thursday - MarketBeat
What catalysts could drive Biodesix Inc. stock higher in 2025Access high-quality stock research instantly - Jammu Links News
How many analysts rate Biodesix Inc. as a “Buy”Free Capital Allocation Plans - Jammu Links News
What are analysts’ price targets for Biodesix Inc. in the next 12 monthsOverwhelming profit margins - Jammu Links News
Is it the right time to buy Biodesix Inc. stockInvest smarter with expert trading signals - Jammu Links News
How strong is Biodesix Inc. company’s balance sheetFree Capital Allocation Plans - Jammu Links News
What analysts say about Biodesix Inc. stockDiscover high-growth stocks for your portfolio - Jammu Links News
How does Biodesix Inc. compare to its industry peersStay ahead with advanced stock screening tools - Jammu Links News
How does Biodesix Inc. generate profit in a changing economyStock Strategy Trend Scanner For Every Investor - jammulinksnews.com
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.12%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):